Kynam Capital Discloses 8.7M Share Stake in Burning Rock Biotech

TL;DR

**Kynam Capital just revealed a big 8.7M share stake in Burning Rock Biotech, signaling institutional confidence.**

AI Summary

Kynam Capital Management, LP, a Delaware-based investment firm, reported owning 8,694,426 Class A Ordinary Shares of Burning Rock Biotech Ltd (BRCK) as of December 31, 2023. This filing, an SC 13G, indicates Kynam Capital holds a significant passive stake in the medical laboratories company. This matters to investors because a large institutional holding by a firm like Kynam Capital can signal confidence in Burning Rock Biotech's future prospects, potentially influencing other investors' perceptions and the stock's stability.

Why It Matters

A significant passive stake by an institutional investor like Kynam Capital can be seen as a vote of confidence in Burning Rock Biotech, potentially attracting more investor interest and providing a floor for the stock price.

Risk Assessment

Risk Level: low — This filing indicates a passive investment, suggesting no immediate intent to influence company management, which generally poses low risk to existing shareholders.

Analyst Insight

Investors should note Kynam Capital's significant stake as a potential indicator of institutional confidence in Burning Rock Biotech, but also monitor future filings for any changes in their position or intent.

Key Numbers

• 8,694,426 — Shares Beneficially Owned (Represents Kynam Capital Management, LP's total holding in Burning Rock Biotech Ltd.)
• December 31, 2023 — Date of Event (The date as of which Kynam Capital Management, LP's ownership stake was determined for this filing.)

Key Players & Entities

• Kynam Capital Management, LP (company) — reporting person, beneficial owner of shares
• Burning Rock Biotech Ltd (company) — subject company, issuer of securities
• 8,694,426 (dollar_amount) — number of shares beneficially owned
• December 31, 2023 (person) — date of event requiring filing
• Delaware (company) — place of organization for Kynam Capital Management, LP

Forward-Looking Statements

• Kynam Capital Management, LP will maintain its passive stake in Burning Rock Biotech Ltd for the foreseeable future. (Kynam Capital Management, LP) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• bnr_11024.htm (SC 13G) — 42KB
• 0001085146-24-000195.txt ( ) — 43KB

(a)

ITEM 1(a). NAME OF ISSUER: Burning Rock Biotech Limited

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: No.5, Xingdaohuan North Road, International Biotech Island, Guangzhou, 510005, Peoples Republic of China

(a)

ITEM 2(a). NAME OF PERSON FILING: Kynam Capital Management, LP Kynam Capital Management GP, LLC Yue Tang

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 221 Elm Road. Princeton, NJ 08540

(c)

ITEM 2(c). CITIZENSHIP: Delaware Delaware U.S.

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Class A Ordinary Shares

(e)

ITEM 2(e). CUSIP NUMBER: 12233L107 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 8,694,426 (b) Percent of class: 10.19% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Kynam Capital Management, LP : Kynam Capital Management GP, LLC : Yue Tang : (ii) shared power to vote or to direct the vote: Kynam Capital Management, LP : 8,694,426 Kynam Capital Management GP, LLC : 8,694,426 Yue Tang : 8,694,426 (iii) sole power to dispose or direct the disposition of: Kynam Capital Management, LP : Kynam Capital Management GP, LLC : Yue Tang : (iv) shared power to dispose or to direct the disposition of: K

View Full Filing

View this SC 13G filing on SEC EDGAR